Abstract
This paper focuses on the child rights implications of bringing new substances into the global drug control regime. Focusing on the examples of ketamine and khat, which in turn highlight the issues of access to medicines (SDG 3) and child labour (SDG 8), it outlines the process for placing substances under international control and the child rights implications of such decisions. To date, however, child rights law has not been featured in this procedure. While child rights law may not be determinative in terms of outcome, the chapter focuses on an important process in global drug policy governance. If decisions to place substances under international control within the drug control architecture of the United Nations engage the obligations of child rights treaties, then there is a strong case for formally taking the obligations arising under those treaties into account.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Revue internationale de politique de développement
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
